共 10 条
Development of Ligand Incorporated Chitosan Nanoparticles for the Selective Delivery of 5-Fluorouracil to Colon
被引:0
作者:
Li, Puwang
[1
,2
,3
]
Peng, Zheng
[3
]
She, F. H.
[1
]
Kong, L. X.
[1
]
机构:
[1] Deakin Univ, Ctr Mat & Fiber Innovat, Inst Technol Res Innovat, Geelong, Vic 3217, Australia
[2] Chinese Acad Trop Agr Sci, Res Inst Trop Agr Machinery, Zhanjiang 524091, Peoples R China
[3] Chinese Acad Trop Agr Sci, Inst Agr Prod Proc Res, Zhanjiang, Peoples R China
来源:
NEW AND ADVANCED MATERIALS, PTS 1 AND 2
|
2011年
/
197-198卷
关键词:
Chitosan;
Folate;
Drug Delivery Systems;
Nanoparticles;
DRUG-DELIVERY;
IN-VITRO;
CANCER;
D O I:
10.4028/www.scientific.net/AMR.197-198.238
中图分类号:
TH [机械、仪表工业];
学科分类号:
0802 ;
摘要:
Drug delivery systems with active targeting ligand provide improved therapeutic efficiency due to the selectivity towards tumor cells. In this paper we prepared drug loaded nanoparticles (NPs) using folate (FA) incorporated chitosan (FA-CS) based on ionic gelation technology. FA-CS NPs were spherical in shape with an average particle size of 100 nm, while 5-fluorouracil (5-FU) loaded NPs became less circular with average particle size of 100-500 nm. NPs made from FA-CS conjugates exhibited improved capability to encapsulate hydrophilic 5-FU. It was found 5-FU distributed in FA-CS NPs in solid solution state. In vitro release results demonstrated the release of 5-FU from FA-CS NPs was more controllable as compared to that of CS NPs.
引用
收藏
页码:238 / +
页数:2
相关论文